Gilead Must Foot $1.8M Bill For 'Egregious' Litigation Conduct
Law 360
JULY 22, 2021
The Delaware chancellor on Thursday chastised Gilead Sciences Inc. million in attorney fees for shareholders who battled Gilead's "overly aggressive" efforts to shut down investigations into its potential malfeasance regarding its AIDS drug development.
Let's personalize your content